secwatch.observer — SEC 8-K summary
======================================

Issuer:     Emergent BioSolutions Inc. (EBS)
CIK:        0001367644
Form:       8-K
Filed at:   2024-01-09T23:59:59+00:00
Accession:  0001367644-24-000002
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Emergent BioSolutions announces presentation at J.P. Morgan conference; no material news disclosed
--------------------------------------------------------------------------------

- Company to present at 42nd Annual J.P. Morgan Healthcare Conference on Jan 11, 2024 at 9:00 a.m. PT.
- Presenters: Interim CEO Haywood Miller and CFO Rich Lindahl.
- Press release and slide deck furnished as exhibits; no financial results or guidance provided.
- Filing is procedural; no material operational or financial updates.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367644/000136764424000002/0001367644-24-000002-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367644/000136764424000002/ebs-20240109.htm
  HTML page:      https://secwatch.observer/filing/0001367644-24-000002

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer